Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |